Protective effect of beta-blockade on dipyridamole-induced myocardial ischaemia - Role of heart rate

N. Ferrara, F. Coltorti, D. Leosco, S. Sederino, P. Abete, P. Caccese, P. Landing, G. Longobardi, R. Verde, F. Rengo

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

This study was designed to investigate the effect of heart rate changes on dipyridamole echocardiographic tests in patients with coronary artery disease treated with propranolol. We prospectively studied 12 patients (8 men and 4 women; mean age 56.5 ± 8.7 years) selected by: (a) angiographic evidence of significant coronary artery disease; (b) adequate echocardiographic window; (c) positive dipyridamole echocardiography test results in baseline conditions (step I); (d) test reproducibility in the absence of treatment; (e) negative dipyridamole echocardiography test results after 7 days of treatment with propranolol (120 mg . day-1) in twice divided doses daily (step II). In all patients treated with propranolol, dipyridamole echocardiographic testing was repeated 24 h after the last negative test. In these patients, transoesophageal atrial pacing was performed at peak dipyridamole infusion to increase heart rate to values similar to those observed at baseline (step III). At baseline, heart rate and rate-pressure product were significantly lower in patients treated with propranolol ( - 20.3% and - 22.5% in group II, P

Original languageEnglish
Pages (from-to)903-908
Number of pages6
JournalEuropean Heart Journal
Volume16
Issue number7
Publication statusPublished - 1995

Fingerprint

Myocardial Ischemia
Dipyridamole
Heart Rate
Echocardiography
Propranolol
Coronary Artery Disease
Baseline
Reproducibility
Testing
Dose
Pressure
Therapeutics

Keywords

  • Atrial pacing
  • Beta-adrenoceptor blockade
  • Dipyridamole
  • Echocardiography
  • Myocardial ischaemia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Physiology

Cite this

Ferrara, N., Coltorti, F., Leosco, D., Sederino, S., Abete, P., Caccese, P., ... Rengo, F. (1995). Protective effect of beta-blockade on dipyridamole-induced myocardial ischaemia - Role of heart rate. European Heart Journal, 16(7), 903-908.

Protective effect of beta-blockade on dipyridamole-induced myocardial ischaemia - Role of heart rate. / Ferrara, N.; Coltorti, F.; Leosco, D.; Sederino, S.; Abete, P.; Caccese, P.; Landing, P.; Longobardi, G.; Verde, R.; Rengo, F.

In: European Heart Journal, Vol. 16, No. 7, 1995, p. 903-908.

Research output: Contribution to journalArticle

Ferrara, N, Coltorti, F, Leosco, D, Sederino, S, Abete, P, Caccese, P, Landing, P, Longobardi, G, Verde, R & Rengo, F 1995, 'Protective effect of beta-blockade on dipyridamole-induced myocardial ischaemia - Role of heart rate', European Heart Journal, vol. 16, no. 7, pp. 903-908.
Ferrara N, Coltorti F, Leosco D, Sederino S, Abete P, Caccese P et al. Protective effect of beta-blockade on dipyridamole-induced myocardial ischaemia - Role of heart rate. European Heart Journal. 1995;16(7):903-908.
Ferrara, N. ; Coltorti, F. ; Leosco, D. ; Sederino, S. ; Abete, P. ; Caccese, P. ; Landing, P. ; Longobardi, G. ; Verde, R. ; Rengo, F. / Protective effect of beta-blockade on dipyridamole-induced myocardial ischaemia - Role of heart rate. In: European Heart Journal. 1995 ; Vol. 16, No. 7. pp. 903-908.
@article{afc230b7504c455cb9b05f44965ec5dc,
title = "Protective effect of beta-blockade on dipyridamole-induced myocardial ischaemia - Role of heart rate",
abstract = "This study was designed to investigate the effect of heart rate changes on dipyridamole echocardiographic tests in patients with coronary artery disease treated with propranolol. We prospectively studied 12 patients (8 men and 4 women; mean age 56.5 ± 8.7 years) selected by: (a) angiographic evidence of significant coronary artery disease; (b) adequate echocardiographic window; (c) positive dipyridamole echocardiography test results in baseline conditions (step I); (d) test reproducibility in the absence of treatment; (e) negative dipyridamole echocardiography test results after 7 days of treatment with propranolol (120 mg . day-1) in twice divided doses daily (step II). In all patients treated with propranolol, dipyridamole echocardiographic testing was repeated 24 h after the last negative test. In these patients, transoesophageal atrial pacing was performed at peak dipyridamole infusion to increase heart rate to values similar to those observed at baseline (step III). At baseline, heart rate and rate-pressure product were significantly lower in patients treated with propranolol ( - 20.3{\%} and - 22.5{\%} in group II, P",
keywords = "Atrial pacing, Beta-adrenoceptor blockade, Dipyridamole, Echocardiography, Myocardial ischaemia",
author = "N. Ferrara and F. Coltorti and D. Leosco and S. Sederino and P. Abete and P. Caccese and P. Landing and G. Longobardi and R. Verde and F. Rengo",
year = "1995",
language = "English",
volume = "16",
pages = "903--908",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Protective effect of beta-blockade on dipyridamole-induced myocardial ischaemia - Role of heart rate

AU - Ferrara, N.

AU - Coltorti, F.

AU - Leosco, D.

AU - Sederino, S.

AU - Abete, P.

AU - Caccese, P.

AU - Landing, P.

AU - Longobardi, G.

AU - Verde, R.

AU - Rengo, F.

PY - 1995

Y1 - 1995

N2 - This study was designed to investigate the effect of heart rate changes on dipyridamole echocardiographic tests in patients with coronary artery disease treated with propranolol. We prospectively studied 12 patients (8 men and 4 women; mean age 56.5 ± 8.7 years) selected by: (a) angiographic evidence of significant coronary artery disease; (b) adequate echocardiographic window; (c) positive dipyridamole echocardiography test results in baseline conditions (step I); (d) test reproducibility in the absence of treatment; (e) negative dipyridamole echocardiography test results after 7 days of treatment with propranolol (120 mg . day-1) in twice divided doses daily (step II). In all patients treated with propranolol, dipyridamole echocardiographic testing was repeated 24 h after the last negative test. In these patients, transoesophageal atrial pacing was performed at peak dipyridamole infusion to increase heart rate to values similar to those observed at baseline (step III). At baseline, heart rate and rate-pressure product were significantly lower in patients treated with propranolol ( - 20.3% and - 22.5% in group II, P

AB - This study was designed to investigate the effect of heart rate changes on dipyridamole echocardiographic tests in patients with coronary artery disease treated with propranolol. We prospectively studied 12 patients (8 men and 4 women; mean age 56.5 ± 8.7 years) selected by: (a) angiographic evidence of significant coronary artery disease; (b) adequate echocardiographic window; (c) positive dipyridamole echocardiography test results in baseline conditions (step I); (d) test reproducibility in the absence of treatment; (e) negative dipyridamole echocardiography test results after 7 days of treatment with propranolol (120 mg . day-1) in twice divided doses daily (step II). In all patients treated with propranolol, dipyridamole echocardiographic testing was repeated 24 h after the last negative test. In these patients, transoesophageal atrial pacing was performed at peak dipyridamole infusion to increase heart rate to values similar to those observed at baseline (step III). At baseline, heart rate and rate-pressure product were significantly lower in patients treated with propranolol ( - 20.3% and - 22.5% in group II, P

KW - Atrial pacing

KW - Beta-adrenoceptor blockade

KW - Dipyridamole

KW - Echocardiography

KW - Myocardial ischaemia

UR - http://www.scopus.com/inward/record.url?scp=0029093485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029093485&partnerID=8YFLogxK

M3 - Article

C2 - 7498204

AN - SCOPUS:0029093485

VL - 16

SP - 903

EP - 908

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 7

ER -